Invite: Corporate Access – Roadshow: Barclays Hosted: Moderna, Inc. (MRNA) - New York

Research evidence excerpt

Invite: Corporate Access – Roadshow: Barclays Hosted: Moderna, Inc. (MRNA) - New York

Eliana Merle, CFA, joined Barclays in November 2025 as

an Equity Research Analyst to cover U.S. Small & Mid Cap

Biotechnology. She has over a decade of sell-side equity

research experience in the sector; most recently, Ellie

worked as a Senior Equity Research Analyst at UBS in

Biotechnology for five years. Prior to that, she also

covered Small & Mid Cap Biotechnology at Cantor

Fitzgerald and held positions at Credit Suisse and

Deutsche Bank in Biotechnology Equity Research. Ellie

graduated from Pomona College with a degree in

Economics.

View Analyst Page

U.S. Small & Mid Cap Biotechnology

Eliana Merle, CFA

+1 212 526 9445

BCI, US

This event is intended for Barclays institutional investor clients only. This event is strictly and solely

for the benefit of the intended recipients. Please do not forward this invitation to any other party

without written consent from Barclays Research. Barclays' Investment Bankers are prohibited from

attending this event. Participant comments are not for attribution.

If your firm is in-scope for research unbundling under MiFID II and you require further information

regarding pricing to participate in this Barclays Research content event, please contact your sales

representative.

Barclays Events Terms of Service | Barclays Events Privacy Notice

Disclaimer:

BARCLAYS

This communication has been prepared by Barclays.

“Barclays” means any entity within the Barclays Group of companies, where “Barclays Group” means

Barclays Bank PLC, Barclays PLC and any of their subsidiaries, affiliates, ultimate holding company

and any subsidiaries or affiliates of such holding company.

CONFLICTS OF INTEREST

BARCLAYS IS A FULL SERVICE INVESTMENT BANK.